Breast cancer survivors found more likely to need hospital care, antidepressants than cancer-free women.
Greatest risk of burnout in palliative care for younger doctors and those working more than 50 hours per week.
Trastuzumab and vinorelbine an effective alternative to standard taxane-based chemotherapy for HER2-positive breast cancer.
Dual therapy with rapamycin (sirolimus) and dasatinib may be an effective treatment for breast cancer.
Link found between a man's number of female sexual partners and his risk of getting prostate cancer.
Palliative Care in Oncology Symposium: Limited time, support, and case management among barriers that hinder ability to provide palliative care.
Successful management of severe cancer pain can be a challenge for oncologists and their patients.
Palliative Care in Oncology Symposium: Dispositional mindfulness may promote flourishing when confronting cancer.
Researchers used degarelix trial questionnaire to address lack of evidence-based information related to quality of life issues in prostate cancer patients.
FDA has designated Keytruda (pembrolizumab) as breakthrough therapy for ALK-negative non-small cell lung cancer (NSCLC).
Trastuzumab + paclitaxel in early stage human epidermal growth factor receptor 2 (HER2)-positive breast cancer reduces recurrence.
Palliative Care in Oncology Symposium: Palliative care for non-small cell lung cancer may not increase healthcare costs in the last 30 days of life.
Palliative Care in Oncology Symposium: Clinicians utilize six key elements, four longitudinal approaches and three specific techniques.
Those who know they have greater risk of colorectal cancer found no more likely to be screened.
Palonosetron an effective option for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients up to age 17.
Health sector prices explain much of difference between U.S. and other high-spending countries.
Millions signing up for Medicaid to comply with federal health care law.
Almost 80% of doctors in the United States have switched from paper to electronic health records.
Most physicians believe that doctors order too many medical tests, yet half admit to doing so themselves in response to a patient who insists, a new survey shows.
Several modifiable risk factors can cut chronic disease deaths over the next 15 years.
Caucasian women overestimate their risk of breast cancer while African American and Hispanic women underestimate their risk, according to research presented at BCS 2013.
A survey presented at BCS 2013 has found a number of factors that cause rural US women to avoid breast cancer screening.
The benefit of perioperative MRI for women with ductal carcinoma in situ (DCIS) is "uncertain," found a study presented during BCS 2013.
ChemotherapyAdvisor.com Editorial Board member Dr. Edith Perez of the Mayo Clinic, Jacksonville, FL, recommends high impact abstracts at the Breast Cancer Symposium 2013.
Women who underwent radiation for ductal carcinoma in situ do not face an increased risk of cardiovascular disease, found a study presented at BCS 2013.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|